HI homepage

New radiotracers outperform FDA-approved agent for detection of tau tangles.

If approved, the two agents could offer providers greater insight into the process of patients’ neurodegeneration.

Melissa Davis, MD, MBA, Yale University, explains her research into private equity market penetration in radiology.

Melissa Davis, MD, vice chair of medical informatics and associate professor at Yale University’s Department of Radiology and Biomedical Imaging, shares her findings from research on private equity market penetration.

 

radiology reporting EHR health record CDS AUC

The University of Pennsylvania in Philadelphia has aimed to tackle this conundrum, developing a deep learning-based image analysis tool and AI “orchestrator.” 

Evergreen Theragnostics

Founded in 2019, Evergreen develops and manufactures imaging agents aimed at diagnosing and treating cancer, including Octevy for neuroendocrine tumors. 

Quibim CEO Ángel Alberich-Bayarri

The Spain-based company offers a suite of solutions to aid in interpreting MRI, CT, and PET scans, boasting 170 installations across the globe. 

Tembo Embolic System

The bioresorbable agent is made from small irregularly shaped, dry gelatin particles designed for the embolization of hypervascular tumors and blood vessels. 

Around the web

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.